| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/02/1996 | WO1996012475A1 Active agent transport systems |
| 05/02/1996 | WO1996012474A1 Compositions for the delivery of antigens |
| 05/02/1996 | WO1996012473A1 Compounds and compositions for delivering active agents |
| 05/02/1996 | WO1996012472A1 Liposome composition containing selegilin |
| 05/02/1996 | WO1996012471A1 Novel and improved aminoglycoside formulation for aerosolization |
| 05/02/1996 | WO1996012470A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
| 05/02/1996 | WO1996012466A1 Controlled release container with core and outer shell |
| 05/02/1996 | CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 05/02/1996 | CA2203118A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
| 05/02/1996 | CA2202510A1 Controlled release container with core and outer shell |
| 05/02/1996 | CA2202299A1 Compositions for the delivery of antigens |
| 05/01/1996 | EP0709099A2 An aqueous nasal suspension comprising cyclodextrin |
| 05/01/1996 | EP0709088A1 Transdermal therapeutic system for application of naloxone |
| 05/01/1996 | EP0709087A1 Medicinal and/or nutritional microcapsules for oral administration |
| 05/01/1996 | EP0709086A2 Discrete particles and method of making same |
| 05/01/1996 | EP0709085A1 Sustained-release preparation |
| 05/01/1996 | EP0708805A1 Seals for use in an aerosol delivery device |
| 05/01/1996 | EP0708671A1 Drug delivery |
| 05/01/1996 | EP0708670A1 Method and apparatus for sealing implantable, membrane encapsulation devices |
| 05/01/1996 | EP0708662A1 Injectable polysaccharide-cell compositions |
| 05/01/1996 | EP0708657A1 Compositions for nasal administration of desmopressin |
| 05/01/1996 | EP0708646A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions |
| 05/01/1996 | EP0708643A1 Transdermal melatonin delivery system |
| 05/01/1996 | EP0708637A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 05/01/1996 | EP0708636A1 Pack for use in, and method of hormonal replacement therapy |
| 05/01/1996 | EP0708627A1 Method and device for providing nicotine replacement therapy transdermally/transbuccally |
| 05/01/1996 | EP0519926B1 Transdermal system |
| 05/01/1996 | EP0497956B1 Controlled release formulations |
| 05/01/1996 | EP0467954B1 Preparation of liposome and lipid complex compositions |
| 05/01/1996 | CN1121694A Cyclosporin-containing powder composition |
| 05/01/1996 | CN1121692A Composition containing cholestyramine and method of producing the same |
| 05/01/1996 | CN1121688A Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
| 05/01/1996 | CN1121420A Preparation of Sanbian panaquilon pill |
| 05/01/1996 | CN1121416A Multi-function ointment for scald |
| 04/30/1996 | US5512598 Dietary vaccine for inhibiting metabolism of methanol |
| 04/30/1996 | US5512597 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials |
| 04/30/1996 | US5512547 Pharmaceutical composition of botulinum neurotoxin and method of preparation |
| 04/30/1996 | US5512332 Process of making resuspendable coated magnetic particles |
| 04/30/1996 | US5512314 Containing immobilizing metal salt to keep dye from migrating; smooth, uniform coating |
| 04/30/1996 | US5512303 Injectable pharmaceutical composition |
| 04/30/1996 | US5512302 Pharmaceutical process using starch |
| 04/30/1996 | US5512301 Collagen-containing sponges as drug delivery compositions for proteins |
| 04/30/1996 | US5512300 Heating to form a melt, combining with alkali metal to forge amalgamation, mixing into homogeneous paste for inclusion in a compound without disrupting |
| 04/30/1996 | US5512299 Controlled delivering of beclomethasone dipropionate by means of an osmotic delivery device |
| 04/30/1996 | US5512298 Cytarabine ocfosfate hard capsule |
| 04/30/1996 | US5512297 Sustained release heterodisperse hydrogel systems for insoluble drugs |
| 04/30/1996 | US5512295 Synthetic liposomes for enhanced uptake and delivery |
| 04/30/1996 | US5512293 Oral sustained release drug delivery device |
| 04/30/1996 | US5512292 Transdermal contraceptive formulations methods and devices |
| 04/30/1996 | US5512289 Spermicidal anti-viral lubricant composition and method of using same |
| 04/30/1996 | US5512286 Extract from leaves of ginkgo biloba for intravenous injection or infusion |
| 04/30/1996 | US5512278 Ointment base useful for pharmaceutical preparations |
| 04/30/1996 | US5512274 Metal hydroxide deodorant formulation |
| 04/30/1996 | US5512270 Respiratory system disorders, parkinson's disease, gastrointestinal disorders |
| 04/30/1996 | US5512269 Method of treating retained pulmonary secretions |
| 04/30/1996 | US5512268 Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof |
| 04/30/1996 | US5512092 Method for preparing aqueous emulsion for coating solid pharmaceutical preparations |
| 04/30/1996 | US5512091 Associative polymer hydrogels |
| 04/30/1996 | US5512055 Biocompatible, nonbioerodable polymeric coating into which a biologically active agent is adsorbed for sustained release |
| 04/30/1996 | CA2026278C Use of alkylphosphoric acid compounds for combatting psoriasis disorders |
| 04/30/1996 | CA2015291C Macromolecular endoplasmic reticulum |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011795A1 Compacted medicament supply for generating inhalable medicament particles |
| 04/25/1996 | WO1996011713A1 Genetic material containing composition |
| 04/25/1996 | WO1996011711A1 Saponin preparations and use thereof in iscoms |
| 04/25/1996 | WO1996011707A1 Renibacterium salmoninarum vaccine and method for its preparation |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | WO1996011705A1 Formulations comprising therapeutically-active proteins or polypeptides |
| 04/25/1996 | WO1996011704A1 A pharmaceutical formulation comprising a growth hormone and leucine |
| 04/25/1996 | WO1996011703A1 A pharmaceutical formulation comprising a growth hormone and isoleucine |
| 04/25/1996 | WO1996011702A1 A pharmaceutical formulation comprising a growth hormone and valine |
| 04/25/1996 | WO1996011701A1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 04/25/1996 | WO1996011699A1 Pharmaceutical composition of botulinum neurotoxin and method of preparation |
| 04/25/1996 | WO1996011693A1 Dermatosis remedy |
| 04/25/1996 | WO1996011687A1 Sabeluzole oral suspensions |
| 04/25/1996 | WO1996011676A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 04/25/1996 | WO1996011675A2 Medicinal and/or nutritional microcapsules for per os administration |
| 04/25/1996 | WO1996011674A1 Method for preparing controlled release pharmaceutical forms |
| 04/25/1996 | WO1996011673A1 Pad for applying medicaments |
| 04/25/1996 | WO1996011672A1 Lyophilized preparation providing reversibly thermogelling water-base medicinal composition |
| 04/25/1996 | WO1996011671A1 Targeted delivery via biodegradable polymers |
| 04/25/1996 | WO1996011670A1 Ether lipid liposomes and their therapeutic use |
| 04/25/1996 | WO1996011669A1 Lyophilizate of lipid complex of water insoluble camptothecins |
| 04/25/1996 | WO1996011666A1 Particles including degradable material and anti-microbial agent |
| 04/25/1996 | DE4437140A1 Artificial nail for treatment of fungal infection |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202612A1 Formulations comprising therapeutically-active proteins or polypeptides |
| 04/25/1996 | CA2202529A1 Gene-containing compositions |
| 04/25/1996 | CA2202511A1 Targeted delivery via biodegradable polymers |
| 04/25/1996 | CA2202497A1 Particles including degradable material and anti-microbial agent |
| 04/25/1996 | CA2199179A1 Ether lipid liposomes and their therapeutic use |
| 04/24/1996 | EP0708113A1 Process for preparing low molecular weight cellulose ethers |
| 04/24/1996 | EP0707862A1 Inhalation device for powdery substances |
| 04/24/1996 | EP0707853A1 Muscle relaxant pharmaceutical compositions |
| 04/24/1996 | EP0707848A1 Solid pharmaceutical composition comprising an excipient capable of binding water |
| 04/24/1996 | EP0707847A1 Ketoprofen liposomes |
| 04/24/1996 | EP0707846A2 A method for synthesizing a liposome |
| 04/24/1996 | EP0707596A1 Conjugation-stabilized polypeptide compositions |
| 04/24/1996 | EP0707580A1 Magnesium omeprazole |